Pambuccian, Stefan E.
The University of Chicago Medicine,
United States
2024 Rank: 315735
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 456 out of 24457 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 315735 | 352763 |
| Total Cites | 358 | 393 |
| H-index | 8 | 8 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 13 | 13 |
| Number of Single+First+Last Authored Papers | 126 | 126 |
| Total Cites to Single+First+Last Authored Papers | 69 | 70 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 347 | 377 |
| Ratio of Total Citations to Distinct Citing Papers | 1.03 | 1.04 |
| Self-Citation Percentage |
8.91%
|
|
Pambuccian, Stefan E.
Loyola University Chicago,
United States
2023 Rank: 143759
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 242 out of 23576 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 143759 | 153128 |
| Total Cites | 416 | 463 |
| H-index | 9 | 9 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 5 | 5 |
| Total Cites to Single Authored Papers | 26 | 27 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 27 | 28 |
| Number of Single+First+Last Authored Papers | 125 | 125 |
| Total Cites to Single+First+Last Authored Papers | 97 | 102 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 392 | 426 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.09 |
| Self-Citation Percentage |
10.15%
|
|
Pambuccian, Stefan E.
Loyola University Medical Center,
United States
2022 Rank: 97814
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 181 out of 23010 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 97814 | 116697 |
| Total Cites | 427 | 463 |
| H-index | 9 | 10 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 41 | 41 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 43 | 43 |
| Number of Single+First+Last Authored Papers | 119 | 119 |
| Total Cites to Single+First+Last Authored Papers | 115 | 118 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 399 | 428 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.08 |
| Self-Citation Percentage |
7.78%
|
|
Pambuccian, Stefan E.
Loyola University Medical Center,
United States
2021 Rank: 86509
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pathology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 162 out of 22656 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 86509 | 90568 |
| Total Cites | 676 | 734 |
| H-index | 11 | 12 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 68 | 69 |
| Number of Single+First Authored Papers | 7 | 7 |
| Total Cites to Single+First Authored Papers | 71 | 72 |
| Number of Single+First+Last Authored Papers | 116 | 116 |
| Total Cites to Single+First+Last Authored Papers | 189 | 198 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 633 | 674 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.09 |
| Self-Citation Percentage |
7.90%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.